Skip to main content

Table 1 Clinicopathologic features for patients suffering SCLC (n = 60)

From: Transcription factor E2F1 promotes EMT by regulating ZEB2 in small cell lung cancer

Variables N (%) Statistical analysis
HR 95%CI P
Age <60 16(26.67) 1 0.297–1.558 0.362
≥ 60 44(73.33) 0.681
Gender Male 55(91.67) 1 0.900–8.409 0.076
Female 5(8.33) 2.752
Smoking Non-smoker 4(6.67) 1 0.603–4.697 0.321
Smoker 56(93.33) 1.682
Tumor size < 4 cm 24(40.00) 1 0.344–1.397 0.306
≥ 4 cm 36(60.00) 0.693
Clinical stage Limited disease 8(13.33) 1 0.072–0.831 0.024
Extensive disease 52(86.67) 0.224
  1. *represents p<0.05